PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

Celltrion Inc (068270.KS) Sortino Ratio: 1.09

Equity · Currency in KRW · Last updated Jun 5, 2026

Celltrion, Inc., together with its subsidiaries, develops and produces drugs based on proteins for the treatment of oncology in South Korea. The company markets biopharmaceuticals; generic pharmaceuticals; and covid-19 test kits. Its antibody biosimilar pipeline includes CT-P44 that is in phase 3 clinical trial for the treatment of multiple myeloma; CT-P51, which is in phase 3 clinical trial for the treatment of Melanoma, lung cancer; CT-P53, which is in phase 3 clinical trial for the treatment of multiple sclerosis; and CT-P55 that is in phase 3 clinical trial for the treatment of Psoriasis. Celltrion, Inc. was founded in 2002 and is headquartered in Incheon, South Korea.

068270.KS's Sortino Ratio of 1.09 indicates that for each unit of downside volatility, it generates 1.09 units of excess return. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 5, 2026).

Unlike other measures, Sortino only focuses on downside volatility (losses), making it particularly useful for investors more concerned about protecting against drawdowns than overall price swings.

068270.KS Sortino Ratio Rank

068270.KS Sortino Ratio Rank: 56.456
Average

068270.KS ranks above 56.4% of all investments in our database based on Sortino Ratio over the past 12 months, indicating moderate downside protection relative to peers. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with minimal downside volatility → Higher rank
  • Severe or frequent drawdowns → Lower rank
  • Upside volatility → No impact (Sortino doesn't penalize upside swings)

What you can do with this information

  • Returns are proportional to downside risk—neither strong nor weak
  • Evaluate whether downside volatility aligns with your risk tolerance
  • Review higher-ranked alternatives in the same category
  • Monitor rank direction to identify improving or deteriorating trends

068270.KS Sortino Ratio Market Positioning

The chart shows 068270.KS's Sortino Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better downside-adjusted returns.

  • Red zone (bottom 25%): -0.28 or lower
  • Yellow zone (middle 50%): -0.28 to 1.97
  • Green zone (top 25%): 1.97 or higher
  • Top 1%: 6.45+
  • Median: 0.79 — half of all investments score higher

How it compares to other similar stocks

The table compares Celltrion Inc's Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how 068270.KS's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.

SymbolName1Y Sortino Ratio5Y Sortino Ratio10Y Sortino RatioAll Time Sortino Ratio
298060.KSSCM LifeScience Co. Ltd3.45
308080.KSViGenCell Inc3.15
290650.KSL&C Bio Co. Ltd3.04
310210.KSVoronoi Co. Ltd2.42
068270.KSCelltrion Inc1.09
005690.KSPharmicell1.06
207940.KSSamsung Biologics Co Ltd0.55
321550.KSTiumBio Co. Ltd0.54
203400.KSAbion Inc0.48
235980.KSMedPacto Inc0.43

S&P 500 Index

How to choose period

Historical Sortino Ratio

The chart shows 068270.KS's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when 068270.KS consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sortino Ratio Calculator

IHow does 068270.KS fit in your portfolio?

Add your other holdings to see your portfolio's Sortino Ratio and find out.

Analyze Your Portfolio